share_log

領航醫藥生物科技:(A)與建議出售精優藥業控股有限公司(股份代號:858)約19.14%已發行股本及精優藥業控股有限公司所發行合共577,170,000港元之可換股債券有關之非常重大出售事項及關連交易及 (B)股東特別大會通告

INNOVATIVE PHAR: (A) VERY SUBSTANTIAL DISPOSAL AND CONNECTED TRANSACTION IN RELATION TO PROPOSED DISPOSAL OF APPROXIMATELY 19.14% OF THE ISSUED SHARE CAPITAL OF AND AN AGGREGATE OF HK$577,170,000 CONVERTIBLE BONDS ISSUED BY EXTRAWELL PHARMACEUTICAL HOLDIN

Sep 12, 2019 04:55
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more